iTeos Therapeutics, Inc. to Post FY2023 Earnings of ($3.84) Per Share, HC Wainwright Forecasts (NASDAQ:ITOS)

iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Equities research analysts at HC Wainwright boosted their FY2023 EPS estimates for iTeos Therapeutics in a research report issued to clients and investors on Wednesday, November 8th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings of ($3.84) per share for the year, […]

Related Keywords

Switzerland ,Swiss , ,Boxer Capital Llc ,Swiss National Bank ,Metlife Investment Management ,Jpmorgan Chase Co ,Iteos Therapeutics Inc ,Teos Therapeutics Company Profile ,Securities Exchange Commission ,Nasdaq ,Teos Therapeutics Inc ,York Mellon Corp ,Teos Therapeutics ,Free Report ,Teos Therapeutic ,National Bank ,New York Mellon Corp ,Life Investment Management ,Rhumbline Advisers ,Boxer Capital ,Exchange Commission ,Teos Therapeutics Company ,Get Free Report ,Teos Therapeutics Daily ,Iteos Therapeutics ,Nasdaq Itos ,Leitos ,Medical ,Earnings Estimates ,Hc Wainwright ,